Qt imaging announces second blinded screening trial finding its technology similarly effective as digital breast tomosynthesis

Novato, calif.--(business wire)--qt imaging holdings, inc. (nasdaq:qti) a medical device company engaged in research, development, and commercialization of innovative body imaging systems is proud to announce positive data regarding the diagnostic performance of qti's breast acoustic cttm scans for mass detection from its second blinded multi-reader multi-case study. the study was published in academic radiology, online, in january 2024: a multireader multicase (mrmc) receiver operating charact.
QTI Ratings Summary
QTI Quant Ranking